Creator Post Archive
Martin Shkreli
Browse the full post archive, then jump into the source post to inspect linked mentions and linked signals.
Aug 15, 2025
8/15/25 +46% record high! PGEN, Scorpion SLNO short
The creator discusses a short report released by Scorpion Capital targeting a biotech company, PGEN. He also mentions considering shorting Joby Aviation and briefly touches on UnitedHealth Group (UNH) and SLNO. The creator expresses uncertainty about PGEN's commercialization and potential capital raises, while finding it somewhat attractive at its current valuation.
Aug 7, 2025
8/6/25 +18% IONQ SRPT
The creator discusses earnings reports and financial metrics for several companies, expressing confusion and skepticism about some of the reported figures and guidance. There's a particular focus on revenue, RPO, and cash flow, with mentions of IonQ, SRPT, and other unnamed companies.
Aug 5, 2025
8/5/25 +21% earnings season continues
The creator provides a brief market update, mentioning several stocks and their performance. He highlights Quantum Computing Inc.'s small deal, discusses the performance of various companies like Alcon, Navatas, HIMS, Nvidia, Palantir, Tesla, and Castle Bioscience. He also touches on international stocks like GSK, Shell, Toyota, and Ubisoft.
Aug 4, 2025
8/4/25 +23% - PLTR HIMS later
Martin Shkreli expresses renewed conviction in ATYR, believing it will move in their favor. He also mentions PLTR and HIMS in passing, indicating a potential focus on these stocks later. The creator is also excited to return to a daily routine after working on Immune and ATYR.
Jun 30, 2025
6/30 - INMB failure
The creator discusses the failure of an immune drug, noting that the primary endpoint was not met and the placebo even slightly outperformed the drug. He dismisses subgroup analyses as unreliable and suggests the company will likely not continue investing in this drug.
Jun 27, 2025
6/27 - ONE DAY TO INMB
The creator discusses Inmune Therapeutics (INMB), expressing strong negative sentiment due to potential data issues and a recent PIPE offering. He questions the legality and timing of the offering, suggesting it implies the company is out of money and that the drugs may not be working. He believes both scenarios (good or bad data) lead to legal trouble for the company and investors.
Jun 20, 2025
6-20-25 -45% INMB watch
The creator is launching a new investment club and discusses his past performance and the potential for stock picking over indexing. He mentions Cassava Sciences as a past disappointment and briefly touches on IonQ and Joe Springer's activities.
May 9, 2025
5/9/25 -16% (RIP QBTS)
The creator discusses their heavily shorted QBTS account, expressing frustration with the stock's performance and market dynamics. They also touch on other stocks like Trade Desk, YSL, and TMDX, offering brief opinions on their prospects.
May 1, 2025
4/30/25 part 3 - earnings season!!!
The creator discusses earnings reports for Meta, Microsoft, and Robinhood. While Microsoft and Robinhood had strong results, Meta's guidance was considered weak, though they plan to increase capital expenditures, particularly on AI chips. The creator also touches on potential impacts of tariffs and makes a jab at Elon Musk.
Showing 26-34 of 34 posts · Page 2 of 2